(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are SEQUANA MEDICAL, ONWARD MEDICAL, and ALAN ALLMAN.

Financial Asset	Price	Change	Updated (EST)
SEQUANA MEDICAL (SEQUA.BR)	0.99	35.73%	2024-10-15 12:21:54
ONWARD MEDICAL (ONWD.BR)	6.00	11.15%	2024-10-15 12:21:21
ALAN ALLMAN (AAA.PA)	5.40	8.87%	2024-10-15 12:46:28
FASTNED (FAST.AS)	22.95	7.75%	2024-10-15 12:02:27
REC SILICON (RECSI.OL)	10.13	6.97%	2024-10-15 12:43:05
TECHSTEP (TECH.OL)	13.35	6.8%	2024-10-15 12:44:40
ENSURGE MICROPOWER (ENSU.OL)	0.96	6.74%	2024-10-15 12:27:53
FUT.CLUBE PORTO (FCP.LS)	1.21	6.14%	2024-10-15 12:24:36
SCHIBSTED SER. A (SCHA.OL)	348.20	5.77%	2024-10-15 12:43:30
ADOCIA (ADOC.PA)	5.77	5.68%	2024-10-15 12:46:03

The three biggest losers today are SALMONES CAMANCHAC, ATLANTIC SAPPHIRE, and INTEROIL EXPL PROD.

Financial Asset	Price	Change	Updated (EST)
SALMONES CAMANCHAC (SACAM.OL)	16.80	-16%	2024-10-15 12:43:17
ATLANTIC SAPPHIRE (ASA.OL)	0.18	-12.05%	2024-10-15 12:26:28
INTEROIL EXPL PROD (IOX.OL)	2.85	-8.26%	2024-10-15 12:40:45
DNO (DNO.OL)	11.42	-7.46%	2024-10-15 12:27:31
BELUGA (BELU.BR)	1.50	-6.25%	2024-10-15 12:06:34
AFFLUENT MEDICAL (AFME.PA)	1.60	-5.88%	2024-10-15 12:46:16
2020 BULKERS (2020.OL)	143.90	-5.82%	2024-10-15 12:25:40
IDEX BIOMETRICS (IDEX.OL)	0.19	-5.64%	2024-10-15 12:40:43
ELKEM (ELK.OL)	19.97	-5.62%	2024-10-15 12:27:41
ALFEN (ALFEN.AS)	12.45	-5.61%	2024-10-15 12:00:23

Winners today

1. SEQUANA MEDICAL (SEQUA.BR)

35.73% Price Change

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL rising 35.73% to €0.99 on Tuesday, after two sequential sessions in a row of gains. BEL 20 rose 0.12% to €4,315.69, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-0.91.

More news about SEQUANA MEDICAL.

2. ONWARD MEDICAL (ONWD.BR)

11.15% Price Change

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.

BEL 20 ended the session with ONWARD MEDICAL rising 11.15% to €6.00 on Tuesday while BEL 20 rose 0.12% to €4,315.69.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -133.61%.

Volume

Today’s last reported volume for ONWARD MEDICAL is 247015 which is 970.34% above its average volume of 23078.

Yearly Top and Bottom Value

ONWARD MEDICAL’s stock is valued at €6.00 at 22:40 EST, below its 52-week high of €6.58 and way above its 52-week low of €1.85.

Moving Average

ONWARD MEDICAL’s worth is way higher than its 50-day moving average of €4.90 and way higher than its 200-day moving average of €4.79.

More news about ONWARD MEDICAL.

3. ALAN ALLMAN (AAA.PA)

8.87% Price Change

CAC 40 ended the session with ALAN ALLMAN jumping 8.87% to €5.40 on Tuesday while CAC 40 fell 1.05% to €7,521.97.

Earnings Per Share

As for profitability, ALAN ALLMAN has a trailing twelve months EPS of €0.13.

PE Ratio

ALAN ALLMAN has a trailing twelve months price to earnings ratio of 41.54. Meaning, the purchaser of the share is investing €41.54 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.5%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 75.2%, now sitting on 320.94M for the twelve trailing months.

Yearly Top and Bottom Value

ALAN ALLMAN’s stock is valued at €5.40 at 22:40 EST, way below its 52-week low of €8.44.

Moving Average

ALAN ALLMAN’s worth is way under its 50-day moving average of €9.88 and way below its 200-day moving average of €10.73.

Volume

Today’s last reported volume for ALAN ALLMAN is 480 which is 34.15% below its average volume of 729.

More news about ALAN ALLMAN.

4. FASTNED (FAST.AS)

7.75% Price Change

Fastned B.V., together with its subsidiaries, engages in the construction and operation of charging stations for fully electric cars. The company is also involved in the commercial operation of chargers at charging stations; and management services. It has operations in the Netherlands, Germany, the United Kingdom, Belgium, France, Switzerland, Italy, and other Europe. The company was incorporated in 2012 and is based in Amsterdam, the Netherlands. Fastned B.V. is a subsidiary of Fastned Administratie Stichting.

AEX-Index ended the session with FASTNED rising 7.75% to €22.95 on Tuesday, following the last session’s downward trend. AEX-Index fell 2.52% to €899.42, after two consecutive sessions in a row of gains, on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, FASTNED has a trailing twelve months EPS of €-1.14.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14%.

Sales Growth

FASTNED’s sales growth for the next quarter is 121.7%.

More news about FASTNED.

5. REC SILICON (RECSI.OL)

6.97% Price Change

REC Silicon ASA, together with its subsidiaries, produces and sells silicon materials for the solar and electronics industries worldwide. It offers various Signature Silane gas, a pure form of silicon that produces product for fuel industries comprising specialty gases, including Dichlorosilane, Monochlorosilane, and Disilane for use in the manufacturing processes of flat panel displays, semiconductors, and solar cells; solar grade polysilicon, including NextSi used for multi crystalline and monocrystalline solar ingot and wafer production in the manufacturing of solar modules; and electronic grade polysilicon consisting of float zone-based devices are used in motor control and power conversion processes for hybrid and electric vehicles, wind energy, and high voltage transmission, 5G communications, high-speed trains, internet of things, and big data, as well as Czochralski for manufacturing of semiconductor wafers used in memory processors, optics, and micro electromechanical systems. The company was formerly known as Renewable Energy Corporation ASA and changed its name to REC Silicon ASA in October 2013. REC Silicon ASA was founded in 1996 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with REC SILICON jumping 6.97% to €10.13 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.82% to €1,438.27.

Earnings Per Share

As for profitability, REC SILICON has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -309.33%.

Yearly Top and Bottom Value

REC SILICON’s stock is valued at kr10.13 at 22:40 EST, way under its 52-week high of kr16.19 and way higher than its 52-week low of kr6.11.

More news about REC SILICON.

6. TECHSTEP (TECH.OL)

6.8% Price Change

Techstep ASA operates as a mobile technology company in Norway, Sweden, Denmark, and Poland. The company offers device lifecycle management, mobile data capture, and mobile device management solutions; strategic and technical advisory services; and unified endpoint, endpoint, and application management services. It also provides mobile devices and accessories; and mobile management and security products. Techstep ASA was founded in 2016 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with TECHSTEP rising 6.8% to €13.35 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.82% to €1,438.27.

Earnings Per Share

As for profitability, TECHSTEP has a trailing twelve months EPS of kr-1.16.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.66%.

Yearly Top and Bottom Value

TECHSTEP’s stock is valued at kr13.35 at 22:40 EST, way under its 52-week high of kr15.00 and way above its 52-week low of kr7.45.

More news about TECHSTEP.

7. ENSURGE MICROPOWER (ENSU.OL)

6.74% Price Change

Ensurge Micropower ASA provides energy storage solutions for wearable devices, connected sensors, and other applications in Norway. The company offers solid-state lithium battery technology that enables it to produce rechargeable batteries. It serves hearables, medical and sports/fitness wearables, and home and industrial devices sectors. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 6.74% to €0.96 on Tuesday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.82% to €1,438.27, after four consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-2.92.

Moving Average

ENSURGE MICROPOWER’s value is way higher than its 50-day moving average of kr0.12 and way above its 200-day moving average of kr0.76.

Yearly Top and Bottom Value

ENSURGE MICROPOWER’s stock is valued at kr0.96 at 22:40 EST, way under its 52-week high of kr4.19 and way higher than its 52-week low of kr0.10.

More news about ENSURGE MICROPOWER.

8. FUT.CLUBE PORTO (FCP.LS)

6.14% Price Change

Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.

PSI ended the session with FUT.CLUBE PORTO rising 6.14% to €1.21 on Tuesday, after two consecutive sessions in a row of losses. PSI fell 0.29% to €6,697.52, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €-2.12.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FUT.CLUBE PORTO’s stock is considered to be overbought (>=80).

More news about FUT.CLUBE PORTO.

9. SCHIBSTED SER. A (SCHA.OL)

5.77% Price Change

Schibsted ASA, together with its subsidiaries, operates as a media company. The company operates through Nordic Marketplaces, News Media, Delivery and Growth & Investments segments. It operates online classifieds that provide technology-based services to connect buyers and sellers, and facilitate transactions, including job offers, real estate, cars, travel, consumer goods, and others. The company also publishes newspapers under the VG, Aftenposten, E24, Bergens Tidende, Stavanger Aftenblad, Aftonbladet, Svenska Dagbladet, and Omni brands in paper and digital format; and operates Podme, a podcast platform. In addition, the company distributes newspapers and parcels for businesses and consumers under the Helthjem and Morgenlevering brands. The company operates in Norway, Sweden, Finland, Denmark, other European countries, and internationally. Schibsted ASA was founded in 1839 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with SCHIBSTED SER. A rising 5.77% to €348.20 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.82% to €1,438.27, after four sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, SCHIBSTED SER. A has a trailing twelve months EPS of kr72.79.

PE Ratio

SCHIBSTED SER. A has a trailing twelve months price to earnings ratio of 4.78. Meaning, the purchaser of the share is investing kr4.78 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 55.63%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Sep 3, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 0.61%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 12% and 46.8%, respectively.

Sales Growth

SCHIBSTED SER. A’s sales growth for the next quarter is negative 30.6%.

More news about SCHIBSTED SER. A.

10. ADOCIA (ADOC.PA)

5.68% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA rising 5.68% to €5.77 on Tuesday while CAC 40 slid 1.05% to €7,521.97.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.5.

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €5.77 at 22:40 EST, way under its 52-week high of €16.16 and way higher than its 52-week low of €5.11.

Volume

Today’s last reported volume for ADOCIA is 90511 which is 18.25% above its average volume of 76539.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.66%, a negative 0.11%, and a positive 2.84%.

ADOCIA’s highest amplitude of average volatility was 1.67% (last week), 1.98% (last month), and 2.84% (last quarter).

More news about ADOCIA.

Losers Today

1. SALMONES CAMANCHAC (SACAM.OL)

-16% Price Change

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. Salmones Camanchaca S.A. was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. (SNSE:SALMOCAM) operates as a subsidiary of Camanchaca S.A. (SNSE:CAMANCHACA).

Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC dropping 16% to €16.80 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.82% to €1,438.27.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr-0.87.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.32%.

Sales Growth

SALMONES CAMANCHAC’s sales growth is 70.5% for the present quarter and 17.2% for the next.

More news about SALMONES CAMANCHAC.

2. ATLANTIC SAPPHIRE (ASA.OL)

-12.05% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE sliding 12.05% to €0.18 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.82% to €1,438.27.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-3.6.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

Moving Average

ATLANTIC SAPPHIRE’s worth is way under its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 1438230 which is 48.04% below its average volume of 2768180.

More news about ATLANTIC SAPPHIRE.

3. INTEROIL EXPL PROD (IOX.OL)

-8.26% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD dropping 8.26% to €2.85 on Tuesday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.82% to €1,438.27, after four successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr-1.64.

Yearly Top and Bottom Value

INTEROIL EXPL PROD’s stock is valued at kr2.85 at 22:40 EST, way below its 52-week high of kr11.00 and way higher than its 52-week low of kr1.70.

Revenue Growth

Year-on-year quarterly revenue growth grew by 59.5%, now sitting on 23.96M for the twelve trailing months.

Moving Average

INTEROIL EXPL PROD’s worth is higher than its 50-day moving average of kr2.61 and way under its 200-day moving average of kr3.76.

More news about INTEROIL EXPL PROD.

4. DNO (DNO.OL)

-7.46% Price Change

DNO ASA engages in the exploration, development, and production of oil and gas assets in the Middle East, the North Sea, and West Africa. The company holds 75% operating interests in the Tawke and Peshkabir fields, and 64% operating interests in the e Baeshiqa license located in the Kurdistan region of Iraq; has production licenses across 10 fields Norway and two fields in the United Kingdom; and operating interests in the producing Block CI-27, as well as operates the exploration Block CI-12 in West Africa. DNO ASA was founded in 1971 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with DNO dropping 7.46% to €11.42 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.82% to €1,438.27.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.33%.

Volume

Today’s last reported volume for DNO is 6705820 which is 296.4% above its average volume of 1691650.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 65.6% and a negative 86.7%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 83.8%, now sitting on 1B for the twelve trailing months.

More news about DNO.

5. BELUGA (BELU.BR)

-6.25% Price Change

BEL 20 ended the session with BELUGA falling 6.25% to €1.50 on Tuesday, after five sequential sessions in a row of losses. BEL 20 jumped 0.12% to €4,315.69, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.

More news about BELUGA.

6. AFFLUENT MEDICAL (AFME.PA)

-5.88% Price Change

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL dropping 5.88% to €1.60 on Tuesday while CAC 40 slid 1.05% to €7,521.97.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.53.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.9%.

Volume

Today’s last reported volume for AFFLUENT MEDICAL is 3466 which is 4.05% above its average volume of 3331.

Volatility

AFFLUENT MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.27%, a negative 0.55%, and a positive 1.77%.

AFFLUENT MEDICAL’s highest amplitude of average volatility was 1.46% (last week), 2.03% (last month), and 1.77% (last quarter).

Yearly Top and Bottom Value

AFFLUENT MEDICAL’s stock is valued at €1.60 at 22:40 EST, way under its 52-week high of €2.30 and way higher than its 52-week low of €0.93.

Moving Average

AFFLUENT MEDICAL’s value is under its 50-day moving average of €1.74 and under its 200-day moving average of €1.61.

More news about AFFLUENT MEDICAL.

7. 2020 BULKERS (2020.OL)

-5.82% Price Change

2020 Bulkers Ltd. owns and operates large dry bulk vessels worldwide. It operates eight scrubber fitted 208,000 deadweight tonnage Newcastlemax dry bulk vessels. 2020 Bulkers Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with 2020 BULKERS dropping 5.82% to €143.90 on Tuesday, after five consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.82% to €1,438.27, after four successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, 2020 BULKERS has a trailing twelve months EPS of kr37.3.

PE Ratio

2020 BULKERS has a trailing twelve months price to earnings ratio of 3.86. Meaning, the purchaser of the share is investing kr3.86 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.64%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 25%, now sitting on 65.6M for the twelve trailing months.

Sales Growth

2020 BULKERS’s sales growth is negative 87.8% for the present quarter and negative 85.3% for the next.

More news about 2020 BULKERS.

8. IDEX BIOMETRICS (IDEX.OL)

-5.64% Price Change

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless smart cards, that includes financial payment and access control cards, as well as card-based devices for the storage of digital currencies. It primarily serves smart card manufacturers and similar solution integrators. The company was incorporated in 1996 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS falling 5.64% to €0.19 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.82% to €1,438.27.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-1.07.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -217.51%.

Volatility

IDEX BIOMETRICS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.73%, a negative 1.21%, and a positive 6.92%.

IDEX BIOMETRICS’s highest amplitude of average volatility was 5.62% (last week), 5.81% (last month), and 6.92% (last quarter).

More news about IDEX BIOMETRICS.

9. ELKEM (ELK.OL)

-5.62% Price Change

Elkem ASA engages in the provision of advanced material solutions worldwide. It operates through three segments: Silicones, Silicon Products, and Carbon Solutions. The company offers silicones polymers, including silicone oils, compounds, emulsions, grease, and resins, as well as chlorosilanes, heat cured rubber silicone, liquid silicone rubber, and RTV-1 and RTV-2 silicones. It also provides silicon-based materials comprising silicon, silicon powder/micronized silicon, silica fume/ micro-silica, ferrosilicon, and grain refiners. In addition, the company offers foundry alloys, such as preconditioners, recarburizers, conditioners, nodularizers, inserts, and inoculants; and carbon-based materials comprising carbon electrodes, furnace tapping materials, electrode paste, ramming paste, prebaked electrodes, and furnace lining materials, as well as polymer additives, and oilfield and refractories specialty products. It offers its products to electronics, aerospace, healthcare, personal care, packaging, airbag coating, chemicals, aluminium, electronics, automotive, specialty steel, solar, construction, refractories, oil and gas, ferroalloys, silicon, and aluminium industries. The company was founded in 1904 and is headquartered in Oslo, Norway. Elkem ASA operates as a subsidiary of Bluestar Elkem International Co., Ltd. S.A.

Oslo Børs Benchmark Index_GI ended the session with ELKEM falling 5.62% to €19.97 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.82% to €1,438.27.

Earnings Per Share

As for profitability, ELKEM has a trailing twelve months EPS of kr-0.8.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.37%.

Volume

Today’s last reported volume for ELKEM is 847512 which is 11.96% below its average volume of 962732.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 83.5% and a negative 31.2%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ELKEM’s EBITDA is 0.58.

More news about ELKEM.

10. ALFEN (ALFEN.AS)

-5.61% Price Change

Alfen N.V., through its subsidiaries, engages in the design, engineering, development, production, and service of smart grids, energy storage systems, and electric vehicle charging equipment. The company offers smart grid solutions, including secondary transformer substations for grid operators, devices for grid automation, and proprietary back-end systems for remote management and control of electricity grids, as well as micro-grids; and supplementary offerings to grid connect amongst others PV farms, electric vehicle (EV) fast-charging hubs, and industrial companies. It also provides energy storage systems comprising stationary and mobile battery energy storage solutions for load balancing, peak shaving, grid frequency control, and energy trading solutions, as well as embedded software and back-office solutions that enables remote monitoring, control, and support for storage applications. In addition, the company offers smart and connected electric vehicle chargers for use at the home, retail, workplace, and public locations, as well as an online management platform for charging infrastructure and standardized solutions for smart charging, load balancing, charging hubs, and plug and charge functionalities. It operates primarily in the Netherlands, Austria, Belgium, Finland, France, Germany, Italy, Norway, Poland, Spain, Sweden, Switzerland, the United Kingdom, and the rest of Europe. The company was founded in 1937 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ALFEN sliding 5.61% to €12.45 on Tuesday while AEX-Index slid 2.52% to €899.42.

Earnings Per Share

As for profitability, ALFEN has a trailing twelve months EPS of €0.42.

PE Ratio

ALFEN has a trailing twelve months price to earnings ratio of 29.64. Meaning, the purchaser of the share is investing €29.64 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.65%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 526.27M for the twelve trailing months.

Yearly Top and Bottom Value

ALFEN’s stock is valued at €12.45 at 22:40 EST, way under its 52-week high of €65.30 and above its 52-week low of €11.66.

Volatility

ALFEN’s last week, last month’s, and last quarter’s current intraday variation average was 0.42%, 0.36%, and 2.75%.

ALFEN’s highest amplitude of average volatility was 2.10% (last week), 2.67% (last month), and 2.75% (last quarter).

Sales Growth

ALFEN’s sales growth for the current quarter is 50.5%.

More news about ALFEN.

Stay up to date with our winners and losers daily report